Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NFIB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RPL22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PDXP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RPS21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GUCY1A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HELLS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBX5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HN1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
H2AFV - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC62 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCND3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RWDD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP48 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on